Back-to-basics, 'not fad' diets beat heart disease and diabetes
View as a Web Page
News Medical
 
  Bowel Cancer Bowel Cancer logo  
  The latest bowel cancer news from News Medical  
 ADHD linked to higher risk of irritable bowel syndrome, global study revealsADHD linked to higher risk of irritable bowel syndrome, global study reveals
 
A global meta-analysis found that people with ADHD are significantly more likely to have irritable bowel syndrome (IBS), while the overall risk for other intestinal disorders is not increased. The findings highlight the importance of gut-brain interactions in ADHD and call for further research on microbiome-based therapies.
 
 
 Back-to-basics, 'not fad' diets beat heart disease and diabetesBack-to-basics, 'not fad' diets beat heart disease and diabetes
 
This review examines dietary interventions that can improve cardiometabolic health, highlighting the role of whole foods in reducing heart disease and diabetes.
 
   Adding immunotherapy to chemotherapy after surgery improves survival in colon cancerAdding immunotherapy to chemotherapy after surgery improves survival in colon cancer
 
Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have lagged.
 
   Understanding BRCAness: What It Means for Cancer TreatmentUnderstanding BRCAness: What It Means for Cancer Treatment
 
BRCAness refers to tumors that mimic BRCA1/2 mutation behavior, making them vulnerable to DNA-damaging treatments like PARP inhibitors
 
 Anti-inflammatory diet linked to longer survival in colon cancer patients
 
Patients with colon cancer who consumed an anti-inflammatory diet during a phase 3 clinical trial showed longer overall survival post-treatment compared to those on a proinflammatory diet, according to a Dana-Farber Cancer Institute analysis.
 
 
 Two patients faced chemo. The one who survived demanded a test to see if it was safe.
 
Two patients faced chemo. The one who survived demanded a test to see if it was safe.JoEllen Zembruski-Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan. 29, her family members said. They didn't realize the drug could kill her.
 
 
 Exercise after chemo key for colon cancer survival, study finds
 
Exercise after chemo key for colon cancer survival, study findsPost-chemotherapy exercise significantly boosts disease-free survival in colon cancer patients, underscoring the importance of structured physical activity.
 
 
 Muscle wasting in cancer tied to blood vessel dysfunction
 
Muscle wasting in cancer tied to blood vessel dysfunctionA dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients experience, according to a new study from University of Illinois Chicago researchers.
 
 
 Experts chart path to bring microbiome science into routine clinical care
 
Experts chart path to bring microbiome science into routine clinical careDespite rapid advances in sequencing and bioinformatics, translating microbiome science into clinical practice presents significant challenges, including the lack of standardized protocols, limited clinical evidence, and logistical barriers. This Cell perspective outlines key actions, standardization, robust trial design, and clinician education to move microbiome diagnostics and therapeutics from bench to bedside.
 
 
 TRR 417 initiative aims to unlock new treatments for colorectal cancer
 
TRR 417 initiative aims to unlock new treatments for colorectal cancerIn the realm of colorectal cancer treatments beyond surgery and radiation, one key question gained prominence in recent years: Is the tumor's DNA repair system defective, making it "microsatellite unstable"? Around 15 to 20 percent of all tumors have this trait, making them likely candidates for successful immunotherapy.
 
 
 Triplet therapy significantly improves survival in BRAF V600E-mutated metastatic colorectal cancer
 
Triplet therapy significantly improves survival in BRAF V600E-mutated metastatic colorectal cancerFirst-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival compared to the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer, according to new data from the Phase III BREAKWATER trial led by researchers from The University of Texas MD Anderson Cancer Center.
 
 
 Upper gastrointestinal involvement is common in Egyptian patients with ulcerative colitis
 
Upper gastrointestinal involvement is common in Egyptian patients with ulcerative colitisThis study investigates upper gastrointestinal tract (UGIT) involvement in patients with ulcerative colitis (UC), a condition traditionally considered limited to the colon.
 
 
 Study highlights the lasting toll of colorectal cancer on women's sexual health
 
Study highlights the lasting toll of colorectal cancer on women's sexual healthA new University of British Columbia-led study is shedding light on a long-overlooked consequence of colorectal cancer: the lasting toll it can take on women's sexual health, even years after treatment ends.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025